“…Three metabolites were identified in the LO11174 control strain, including 2,ωdihydroxyemodin (21), 27 3-methylorsellinic acid (22), and an unknown compound (23). Compounds 21−23 were upregulated in the llmG overexpression strains along with 12 additional metabolites (1, 14, 18, 19, and 24−31), including 1 and its intermediates 14, 28 versicolorin B (24), 28 averantin (25), 30 metabolites from the emodin/mondictyphenone pathway, 31 monodictyphenone (26), ω-hydroxyemodin (27), 2hydroxyemodin (28), emodin (29), chrysophanol (30), nidulanins (18 and 19), 13,19 3-methylorsellinic acid (22), 32 and an unknown (31) (Figure 2B, ii−iv). As was the case for GMM(s), we observed an even greater increase in production of the same SMs in the mcrAΔ strain than in the llmG overexpression strains and, notably, the gpdA(p)llmG, mcrAΔ strain demonstrated enhanced SM production in comparison with the mcrAΔ strain (Figure 2B, iii and iv, Supplemental Table 2).…”